Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01693302 · ClinicalTrials.gov registry record · NA
Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT01693302 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 23 participants.
The verdict
NCT01693302, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Blood glucose levels in patients with type 1 diabetes tend to peak after eating a meal due to the delayed action of insulin when compared to carbohydrate absorption from food. It is the hypothesis of the investigator that administering the insulin for a meal 20 minutes before the meal will result in lower blood glucose peaks compared to administration of insulin immediately before or 20 minutes after starting to eat. All subjects will eat the same meal on three different occasions. Insulin will be administered at one of the three times at each visit.
Interventions
- OTHER Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01693302
The ClinicalTrials.gov registry entry for NCT01693302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulin is the first listed.
NCT01693302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01693302 about?
NCT01693302 is a clinical study titled "Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes". Blood glucose levels in patients with type 1 diabetes tend to peak after eating a meal due to the delayed action of insulin when compared to carbohydrate absorption from food. It is the hypothesis of the investigator that administering the insulin for a meal 20 minutes before the meal will result in...
What is the current status of trial NCT01693302?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2007-08. Estimated completion is 2009-05.
What interventions are being tested in trial NCT01693302?
The interventions under investigation include: Insulin (OTHER).
Who is sponsoring clinical trial NCT01693302?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.